Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 4, 2007, Pages 349-354

  Huang, Wan Ting ^a   Chang, Luan Yin ^a   Hsueh, Po Ren ^a   Lu, Chun Yi ^a   Shao, Pei Lan ^a   Huang, Fu Yuan ^b   Lee, Ping Ing ^a   Chen, Chun Ming ^a   Lee, Chin Yun ^a   Huang, Li Min ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Hematology; Neoplasms; Penicillins; Viridans streptococci

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; CEFOTAXIME; COTRIMOXAZOLE; CYTARABINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPERTENSIVE AGENT; PENICILLIN DERIVATIVE; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CANCER CHEMOTHERAPY; CANCER PATIENT; CHILD; CHILD HOSPITALIZATION; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; FEVER; HUMAN; HYPERALIMENTATION; HYPOTENSION; INTENSIVE CARE UNIT; LYMPHOMA; MALE; NEUTROPENIA; OXYGEN THERAPY; PNEUMONIA; RESPIRATORY FAILURE; RISK FACTOR; SOLID TUMOR; STEM CELL TRANSPLANTATION; STREPTOCOCCUS MITIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; MICROBIAL SENSITIVITY TESTS; OPPORTUNISTIC INFECTIONS; PNEUMONIA, BACTERIAL; STEM CELL TRANSPLANTATION; STREPTOCOCCAL INFECTIONS; TAIWAN; VIRIDANS STREPTOCOCCI;

EID: 35748931485     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis. 1999;29:490-4.
2. Johnson CC, Tunkel AR. Viridans streptococci and group C and G streptococci. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005:2434-51.
3. Pizzo PA, Ladisch S, Witebsky FG. Alpha-hemolytic streptococci: clinical significance in the cancer patient. Med Pediatr Oncol. 1978;4:367-70.
4. Hoecker JL, Pickering LK, Groschel D, Kohl S. Streptococcus salivarius sepsis in children with malignancies. J Pediatr. 1978; 92:337-8.
5. Levy CS, Kogulan P, Gill VJ, Croxton MB, Kane JG, Lucey DR. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Clin Infect Dis. 2001;33:577-9.
6. Stock JH, Sahn DJ. Endocarditis in the pediatric population. Curr Treat Options Cardiovasc Med. 2000;2:481-8.
7. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002; 34:1524-9.
8. Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med. 1994; 97:256-64.
9. Galanakis E, Kritikou-Pliota E, Pappa C, Siamopoulou A, Papadopoulou ZL. Streptococcus mitis septicaemia and hepatitis. Scand J Infect Dis. 2000;32:214-5.
10. Bochud PY, Eggiman P, Calandra T, Van Meile G, Saghafi L, Francioli P. Bacteremia due to viridans Streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis. 1994;18:25-31.
11. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis. 1992;14:1201-7.
12. Diekema DJ, Coffman SL, Marshall SA, Beach ML, Rolston KV, Jones RN. Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 Gram-positive cocci recently isolated in cancer treatment centers. Antimicrob Agents Chemother. 1999;43:940-3.
13. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother. 1996;40:891-4.
14. McWhinney PH, Patel S, Whiley RA, Hardie JM, Gillespie SH, Kibbler CC. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother. 1993;37: 2493-5.
15. Shenep JL, Hughes WT, Roberson PK, Blankenship KR, Baker DK, Meyer WH, et al. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med. 1988;319:1053-8.
16. Chen CY, Tang JL, Hsueh PR, Yao M, Huang SY, Chen YC, et al. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. J Formos Med Assoc. 2004;103: 526-32.
17. Lai HP, Hsueh PR, Chen YC, Lee PI, Lu CY, Lu MY, et al. Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan. J Microbiol Immunol Infect. 2003;36:197-202.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests. Approved standard M2-A6, 6th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997.
19. Liang DC, Chang TT, Lin KH, Lin DT, Lu MY, Chen SH, et al. Improved treatment results for childhood acute myeloid leukemia in Taiwan. Leukemia. 2006;20:136-41.
20. Paganini H, Staffolani V, Zubizarreta P, Casimir L, Lopardo H, Luppino V. Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors. Eur J Cancer. 2003;39:1284-9.
21. Garnis AS, Howells WB, DeSwarte-Wallace J, Feusner JH, Buckley JD, Woods WG. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the children's cancer group study CCG-2891. J Clin Oncol. 2000;18:1845-55.
22. Valteau D, Hartmann O, Brugieres L, Vassal G, Benhamou E, Andremont A, et al. Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Transplant. 1991; 7:415-9.
23. Weisman SJ, Scoopo FJ, Johnson GM, Altman AJ, Quinn JJ. Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J Clin Oncol. 1990;8:453-9.
24. Marron A, Carratalà J, González-Barca E, Fernández-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 2000;31:1126-30.
25. Guiot HF, Corel LJ, Vossen JM. Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders. Eur J Clin Microbiol Infect Dis. 1994;13:645-50.
26. Mogi A, Nishi JI, Yoshinaga M, Harada H, Narahara S, Kawakami K, et al. Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases. Pediatr Infect Dis J. 1997;16: 1140-4.
27. Carratalá J, Alcaide F, Fernández-Sevilla A, Corbella X, Linares J, Gudiol F. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis. 1995;20:1169-73.
28. Bruckner LB, Korones DN, Karnauchow T, Hardy DJ, Gigliotti F. High incidence of penicillin resistance among alpha-hemolytic streptococci isolated from the blood of children with cancer. J Pediatr. 2002;140:20-6.
29. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis. 1997;25:247-59.
30. Sotiropoulos SV, Jackson MA, Woods GM, Hicks RA, Cullen J, Freeman AI. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J. 1989;8: 755-8.